Cargando…

Whole blood transcriptome changes following controlled human malaria infection in malaria pre-exposed volunteers correlate with parasite prepatent period

Malaria continues to be one of mankind’s most devastating diseases despite the many and varied efforts to combat it. Indispensable for malaria elimination and eventual eradication is the development of effective vaccines. Controlled human malaria infection (CHMI) is an invaluable tool for vaccine ef...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rothen, Julian, Murie, Carl, Carnes, Jason, Anupama, Atashi, Abdulla, Salim, Chemba, Mwajuma, Mpina, Maxmillian, Tanner, Marcel, Lee Sim, B. Kim, Hoffman, Stephen L., Gottardo, Raphael, Daubenberger, Claudia, Stuart, Ken
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007927/ https://www.ncbi.nlm.nih.gov/pubmed/29920562 http://dx.doi.org/10.1371/journal.pone.0199392

Ejemplares similares

Early whole blood transcriptional responses to radiation-attenuated Plasmodium falciparum sporozoite vaccination in malaria naïve and malaria pre-exposed adult volunteers
por: Duffy, Fergal J., et al.
Publicado: (2021)

Role of human Pegivirus infections in whole Plasmodium falciparum sporozoite vaccination and controlled human malaria infection in African volunteers
por: Tumbo, Anneth-Mwasi, et al.
Publicado: (2021)

Experience and challenges from clinical trials with malaria vaccines in Africa
por: Mwangoka, Grace, et al.
Publicado: (2013)

The Equatoguinean Malaria Vaccine Initiative: From the Launching of a Clinical Research Platform to Malaria Elimination Planning in Central West Africa
por: Billingsley, Peter F., et al.
Publicado: (2020)

Virosome-Formulated Plasmodium falciparum AMA-1 & CSP Derived Peptides as Malaria Vaccine: Randomized Phase 1b Trial in Semi-Immune Adults & Children
por: Cech, Patrick Georges, et al.
Publicado: (2011)

Controlled Human Malaria Infection of Tanzanians by Intradermal Injection of Aseptic, Purified, Cryopreserved Plasmodium falciparum Sporozoites
por: Shekalaghe, Seif, et al.
Publicado: (2014)

Two cases of long-lasting, sub-microscopic Plasmodium malariae infections in adults from coastal Tanzania
por: Schindler, Tobias, et al.
Publicado: (2019)

Evaluating the effectiveness of IPTi on malaria using routine health information from sentinel health centres in southern Tanzania
por: Willey, Barbara A, et al.
Publicado: (2011)

Molecular malaria surveillance using a novel protocol for extraction and analysis of nucleic acids retained on used rapid diagnostic tests
por: Guirou, Etienne A., et al.
Publicado: (2020)

New equipment optimized for emulsified vaccine prepation in the hospital
por: Ascarateil, Stephane, et al.
Publicado: (2013)

SvSXP: a Strongylus vulgaris antigen with potential for prepatent diagnosis
por: Andersen, Ulla V, et al.
Publicado: (2013)

Transcriptional correlates of malaria in RTS,S/AS01-vaccinated African children: a matched case–control study
por: Moncunill, Gemma, et al.
Publicado: (2022)

Analysis of nucleic acids extracted from rapid diagnostic tests reveals a significant proportion of false positive test results associated with recent malaria treatment
por: Hosch, Salome, et al.
Publicado: (2022)

Molecular detection of prepatent Schistosoma mansoni infection in Biomphalaria glabrata snail vectors
por: Casotti, Márcia Oliveira, et al.
Publicado: (2020)

Proteome-wide analysis of a malaria vaccine study reveals personalized humoral immune profiles in Tanzanian adults
por: Camponovo, Flavia, et al.
Publicado: (2020)

The Effect of Different Formulations of Praziquantel in Reducing Worms in the Prepatent Period of Schistosomiasis in Murine Models
por: Paulino, Érica Tex, et al.
Publicado: (2022)

Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of Plasmodium falciparum Sporozoite Vaccine in Tanzanian Adults
por: Jongo, Said A., et al.
Publicado: (2018)

Malaria Vaccine Yields Parasite-Killing Antibodies in Human Volunteers
Publicado: (2005)

Assessment of parental perception of malaria vaccine in Tanzania
por: Romore, Idda, et al.
Publicado: (2015)

Comparison of bioavailability between the most available generic tablet formulation containing artemether and lumefantrine on the Tanzanian market and the innovator’s product
por: Minzi, Omary MS, et al.
Publicado: (2013)

The impact of Loa loa microfilaraemia on research subject retention during a whole sporozoite malaria vaccine trial in Equatorial Guinea
por: Manock, Stephen R, et al.
Publicado: (2022)

Molecular monitoring of the diversity of human pathogenic malaria species in blood donations on Bioko Island, Equatorial Guinea
por: Schindler, Tobias, et al.
Publicado: (2019)

Advancing Global Health through Development and Clinical Trials Partnerships: A Randomized, Placebo-Controlled, Double-Blind Assessment of Safety, Tolerability, and Immunogenicity of PfSPZ Vaccine for Malaria in Healthy Equatoguinean Men
por: Olotu, Ally, et al.
Publicado: (2018)

Diagnostic performance and comparison of ultrasensitive and conventional rapid diagnostic test, thick blood smear and quantitative PCR for detection of low-density Plasmodium falciparum infections during a controlled human malaria infection study in Equatorial Guinea
por: Mpina, Maxmillian, et al.
Publicado: (2022)

Malaria and Malaria Parasites
Publicado: (1901)

Incidence of Plasmodium falciparum malaria infection in 6-month to 45-year-olds on selected areas of Bioko Island, Equatorial Guinea
por: Nchama, Vicente Urbano Nsue Ndong, et al.
Publicado: (2021)

Providing Ancillary Care in Clinical Research: A Case of Diffuse Large B-Cell Lymphoma during a Malaria Vaccine Trial in Equatorial Guinea
por: Manock, Stephen R., et al.
Publicado: (2021)

The effect of immunization schedule with the malaria vaccine candidate RTS,S/AS01(E) on protective efficacy and anti-circumsporozoite protein antibody avidity in African infants
por: Ajua, Anthony, et al.
Publicado: (2015)

Deliberately infecting healthy volunteers with malaria parasites: Perceptions and experiences of participants and other stakeholders in a Kenyan‐based malaria infection study
por: Jao, Irene, et al.
Publicado: (2020)

Response to “Poor control vaccines in two randomised trials of malaria vaccine?”
por: Bejon, Philip, et al.
Publicado: (2009)

Policy analysis for deciding on a malaria vaccine RTS,S in Tanzania
por: Romore, Idda, et al.
Publicado: (2016)

Volunteer computers in homes to fight against Malaria in Africa
Publicado: (2006)

A public antibody lineage that potently inhibits malaria infection by dual binding to the circumsporozoite protein
por: Tan, Joshua, et al.
Publicado: (2018)

Stakeholders’ opinions and questions regarding the anticipated malaria vaccine in Tanzania
por: Mtenga, Sally, et al.
Publicado: (2016)

Enterobiasis and strongyloidiasis and associated co-infections and morbidity markers in infants, preschool- and school-aged children from rural coastal Tanzania: a cross-sectional study
por: Salim, Nahya, et al.
Publicado: (2014)

Implementation of community case management of malaria in malaria endemic counties of western Kenya: are community health volunteers up to the task in diagnosing malaria?
por: Marita, Enock, et al.
Publicado: (2022)

Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines
por: Richie, Thomas L., et al.
Publicado: (2015)

Understanding the role of serological and clinical data on assessing the dynamic of malaria transmission: a case study of Bagamoyo district, Tanzania
por: Mwamlima, Tunu Guntram, et al.
Publicado: (2022)

Humoral antimalaria immune response in Nigerian children exposed to helminth and malaria parasites
por: Adukpo, Selorme, et al.
Publicado: (2022)

The Malaria Parasite
Publicado: (1900)

Cannot write session to /tmp/vufind_sessions/sess_43749lgsrqq0hvfj65nrols5g5